New study aims to predict heart damage in kids treated for cancer
NCT ID NCT07253077
First seen Jan 09, 2026 · Last updated May 25, 2026 · Updated 16 times
Summary
This study will check if certain substances in the blood can predict heart damage in children and teens who had chemotherapy with anthracyclines. Researchers will compare blood test results and heart scans from 40 childhood cancer survivors to those from healthy kids. The goal is to find early warning signs of heart problems, not to treat them.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHEMOTHERAPEUTIC TOXICITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Roma, 00168, Italy
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.